Consumers can easily re-prompt a chatbot, but enterprises cannot afford mistakes like shutting down the wrong server. This high-stakes environment means AI agents won't be given autonomy for critical tasks until they can guarantee near-perfect precision and accuracy, creating a major barrier to adoption.

Beyond model capabilities and process integration, a key challenge in deploying AI is the "verification bottleneck." This new layer of work requires humans to review edge cases and ensure final accuracy, creating a need for entirely new quality assurance processes that didn't exist before.

OpenAI's health division serves a dual purpose: delivering societal benefits and providing a real-world, high-stakes environment for AI safety research. Problems like scalable oversight (supervising superhuman AI) move from theoretical exercises to practical necessities when models outperform physicians on narrow tasks, creating concrete feedback loops that accelerate safety progress.

Hospitals are adopting a phased approach to AI. They start with commercially ready, low-risk, non-clinical applications like RCM. This allows them to build an internal 'AI muscle'—developing frameworks and expertise—before expanding into more sensitive, higher-stakes areas like patient engagement and clinical decision support.

Treating AI risk management as a final step before launch leads to failure and loss of customer trust. Instead, it must be an integrated, continuous process throughout the entire AI development pipeline, from conception to deployment and iteration, to be effective.

To mitigate risks like AI hallucinations and high operational costs, enterprises should first deploy new AI tools internally to support human agents. This "agent-assist" model allows for monitoring, testing, and refinement in a controlled environment before exposing the technology directly to customers.

In high-stakes fields like healthcare, the cost of an AI error is immense. Product leaders must prioritize safety, reliability, and the reproducibility of outcomes. A complete audit trail is non-negotiable, as it enables the reversal of incorrect decisions and ensures accountability.

Society holds AI in healthcare to a much higher standard than human practitioners, similar to the scrutiny faced by driverless cars. We demand AI be 10x better, not just marginally better, which slows adoption. This means AI will first roll out in controlled use cases or as a human-assisting tool, not for full autonomy.

Dr. Jordan Schlain frames AI in healthcare as fundamentally different from typical tech development. The guiding principle must shift from Silicon Valley's "move fast and break things" to "move fast and not harm people." This is because healthcare is a "land of small errors and big consequences," requiring robust failure plans and accountability.